Physician profile
Heather Thomas
NPI 1497325344
$3,576.01
in general payments reported to CMS, 2019-2025
37 companies · $808 in 2025
The $808 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $620 · 2023: $972 · 2024: $1,064 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,843.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $489.77 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $390.88 | 2022-2025 | |
| Lilly USA, LLC | $288.67 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Astellas Pharma US INC | $204.88 | 2023-2025 | Veozah |
| Corium, LLC | $198.67 | 2022-2025 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $175.23 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $168.09 | 2022-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $166.97 | 2023-2024 | |
| Pfizer INC. | $157.62 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $142.98 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $125.00 | 2022 | |
| Glaxosmithkline, LLC. | $113.87 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Gilead Sciences, INC. | $110.81 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.98 | 2022-2025 | Xifaxan |
| Ironshore Pharmaceuticals INC. | $94.74 | 2023-2024 | Jornay Pm |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $84.89 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.12 | 2023-2024 | Jardiance |
| Supernus Pharmaceuticals, INC. | $57.28 | 2022-2023 | Qelbree |
| Amgen INC. | $57.08 | 2022-2023 | Prolia, Evenity |
| Dynavax Technologies Corporation | $45.93 | 2024 | Heplisav-B |
| Viiv Healthcare Company | $29.58 | 2024 | Apretude |
| Merck Sharp & Dohme LLC | $28.76 | 2022-2023 | Vaxneuvance, Gardasil 9, Varivax |
| Eisai INC. | $26.99 | 2024 | |
| Shield Therapeutics INC | $25.31 | 2023 | Accrufer |
| Sanofi Pasteur INC. | $21.81 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.88 | 2025 | |
| Hologic Sales and Service, LLC | $20.53 | 2023 | Coolseal Generator |
| Mayne Pharma Commercial LLC | $18.00 | 2024 | |
| Dexcom, INC. | $17.97 | 2024 | Dexcom G6 Transmitter |
| Collegium Pharmaceutical, INC. | $17.95 | 2025 | Jornay Pm |
| Axsome Therapeutics, INC. | $15.34 | 2025 | Auvelity |
| Edwards Lifesciences Corporation | $15.00 | 2023 | Sapien 3 Ultra Resilia |
| Phathom Pharmaceuticals, INC. | $14.28 | 2024 | Voquezna |
| Cranial Technologies, INC | $14.16 | 2024 | Doc Band |
| Sanofi-Aventis U.S. LLC | $13.32 | 2022 | |
| Antares Pharma, INC. | $13.11 | 2024 | Xyosted |
| Tris Pharma INC | $12.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.